Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae.
about
Intranasal immunization with killed unencapsulated whole cells prevents colonization and invasive disease by capsulated pneumococciThe O antigen enables Bordetella parapertussis to avoid Bordetella pertussis-induced immunityHow Can Vaccines Contribute to Solving the Antimicrobial Resistance Problem?Controlling antimicrobial resistance through targeted, vaccine-induced replacement of strainsDecrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine7-Valent pneumococcal conjugate vaccination in England and Wales: is it still beneficial despite high levels of serotype replacement?Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005.Antibiotic innovation may contribute to slowing the dissemination of multiresistant Streptococcus pneumoniae: the example of ketolides.Impact of capsular switch on invasive pneumococcal disease incidence in a vaccinated population.The ecology of nasal colonization of Streptococcus pneumoniae, Haemophilus influenzae and Staphylococcus aureus: the role of competition and interactions with host's immune response.Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease.The dynamics of nasopharyngeal streptococcus pneumoniae carriage among rural Gambian mother-infant pairsImpact of a pneumococcal conjugate vaccination program on carriage among children in Norway.Structural and genetic diversity of group B streptococcus capsular polysaccharides.Use of a whole genome approach to identify vaccine molecules affording protection against Streptococcus pneumoniae infection.Diagnosis of invasive pneumococcal infection by serotype-specific urinary antigen detection.Pathogen evolution and the immunological niche.Interactions among strategies associated with bacterial infection: pathogenicity, epidemicity, and antibiotic resistanceClonal analysis of colonizing group B Streptococcus, serotype IV, an emerging pathogen in the United States.Role of pneumococcal surface protein C in nasopharyngeal carriage and pneumonia and its ability to elicit protection against carriage of Streptococcus pneumoniaeShort- and long-term effects of pneumococcal conjugate vaccination of children on penicillin resistanceSerotype replacement in disease after pneumococcal vaccinationMeasuring and interpreting associations between antibiotic use and penicillin resistance in Streptococcus pneumoniae.Linking data and models: the importance of statistical analyses to inform models for the transmission dynamics of infections.Does M. tuberculosis genomic diversity explain disease diversity?Construction and immunological characterization of a novel nontoxic protective pneumolysin mutant for use in future pneumococcal vaccines.Minimizing potential resistance: a population dynamics view.Reevaluation of epidemiological data demonstrates that it is consistent with cross-immunity among human papillomavirus types.Development and evaluation of pneumococcal conjugate vaccines: clinical trials and control tests.Variation in the presence of neuraminidase genes among Streptococcus pneumoniae isolates with identical sequence types.Influence of pneumococcal vaccines and respiratory syncytial virus on alveolar pneumonia, Israel.Update on the success of the pneumococcal conjugate vaccineEvaluation of methodology for serotyping invasive and nasopharyngeal isolates of Haemophilus influenzae in the ongoing surveillance in Brazil.Invited commentary: multiple human papillomavirus infections and type replacement-anticipating the future after human papillomavirus vaccination.Construction of otherwise isogenic serotype 6B, 7F, 14, and 19F capsular variants of Streptococcus pneumoniae strain TIGR4Heterogeneity in the frequency and characteristics of homologous recombination in pneumococcal evolutionVaccine production, distribution, access, and uptake.Glycoconjugate vaccines to prevent group B streptococcal infections.Selective and genetic constraints on pneumococcal serotype switching.Impact of more than a decade of pneumococcal conjugate vaccine use on carriage and invasive potential in Native American communities
P2860
Q24548662-9D987B12-0E2A-4759-8B07-FEAA6D4A60E2Q24672570-3C555F2C-6770-4D9B-938D-6173068F7774Q26748155-48ED42B1-022E-427A-9D27-C05BCF0B9CFFQ28485487-D77540F8-3651-49DB-9A67-C527A8CD2C48Q28732846-DFB8956F-EA75-43C0-AEC5-9EABBF22C3E8Q28743870-33EC4258-2B3E-46E6-8A40-62829966FAD8Q30229111-2A70C460-03E3-4E0C-A1AF-FCA5E9452D40Q33332126-4BAEF05D-55F3-4A48-A9FD-E17555A94625Q33370549-7F7C167D-723B-4BA3-8253-03192BAB86B9Q33533638-C4601CCE-2F7B-4E09-AA38-C8A5A5745CBFQ33551026-2967FA28-671B-4477-A12E-58D156548D83Q33625426-D5EC2501-A0B0-434B-A34C-5C29B67D350BQ33725199-533BBC17-D001-4A6E-85A2-55E17B82E25DQ33768905-A78F7B41-F8CF-495F-B6F2-CE73EAD91CB7Q34006372-DB34D143-1482-44DD-B3E4-40408E958805Q34073477-02C87796-0575-4C07-B12A-FD4BAFCF1605Q34078369-15E74ED3-8078-4CB7-82E1-802E83972DC8Q34102811-2667B65C-BC34-44A2-A575-861F23A12070Q34120642-214A8F4C-C367-479D-9C27-866D504FC616Q34121334-F9CE2CE4-B083-43B3-B3E6-862A4A10EC4CQ34140625-9B512D79-FD3E-4A97-89BA-EB2C5DBAEE72Q34178363-06BC757B-3526-4A02-980A-5A4836722D58Q34192567-9B729F94-2BB2-4E96-85DE-43119AE84F83Q34290122-3BAF89C3-4FFF-4944-BD06-23B896A7BFEFQ34293557-FF4916A1-2A5E-4248-B677-BC343D8D0757Q34301234-2F1B6CF5-E865-48AF-8A47-4F7899A3EB2AQ34347875-0F2EF5FC-94D0-43C7-943C-9E6821536BA0Q34370578-4E6030CB-551D-4FE5-AEC7-E3ED8684AF61Q34632848-ED1F2A2A-53C9-4640-946E-4E471F9BC855Q34681065-B860DF83-4FA3-4985-951B-456EB8B82C71Q34771479-C92E8EC9-29DC-4156-BD2F-2F35BA4D1382Q34789889-8446DEA2-82E9-43AC-BAFB-76ADD25059B7Q34950997-3F111A4D-A0AF-4218-80B4-46CBDD2C4B9CQ34974475-797D2C1B-CE8A-424F-9199-2089867AB4ADQ34998393-1835E707-9927-4068-BDCC-954D9738B9E7Q35160801-50FD7E37-6AEF-4317-A239-57DC8CD0FEBEQ35188985-B73F6BD5-0811-43C6-B96D-CBB07D6984B2Q35207531-44F0BA82-9BF6-4FF1-866B-F98D6560C7A5Q35590891-5FD8372B-BC10-429C-A5D9-81A469A9EC23Q35628669-F1C9ED01-6F51-455D-B732-844BCEBC9C6C
P2860
Bacterial vaccines and serotype replacement: lessons from Haemophilus influenzae and prospects for Streptococcus pneumoniae.
description
1999 nî lūn-bûn
@nan
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
1999年论文
@zh
1999年论文
@zh-cn
name
Bacterial vaccines and serotyp ...... for Streptococcus pneumoniae.
@en
type
label
Bacterial vaccines and serotyp ...... for Streptococcus pneumoniae.
@en
prefLabel
Bacterial vaccines and serotyp ...... for Streptococcus pneumoniae.
@en
P2860
P356
P1476
Bacterial vaccines and serotyp ...... for Streptococcus pneumoniae.
@en
P2860
P304
P356
10.3201/EID0503.990304
P577
1999-05-01T00:00:00Z